Prognos Raises $20.5M in Series C Funding

Prognos, a NYC-based healthcare AI company, raised $20.5M in Series C funding.

Backers included Cigna, GIS Strategic Ventures (the venture capital arm of the Guardian Life Insurance Company), Hermed, Hikma Ventures, Maywic, Merck Global Health Innovation Fund (GHI), and Safeguard Scientifics.

The company, which has raised $42m in total funding to date, will use the funds to continue to expand its business reach.

Led by Sundeep Bhan, Cofounder and CEO, Prognos applies artificial intelligence (AI) to deliver real-time insights based on laboratory and diagnostics records.
Prognos’ solutions enable earlier identification of patients who can benefit from enhanced treatment decision-making, risk management, and quality improvement. The company is currently serving 25 Life Sciences brands to find and convert appropriate patients while building it’s presence in the payer market.
The Prognos Registry gives clinical diagnostics information in 50 disease areas, with over 13B medical records for 180M patients. It also has 1000 extensive proprietary and learning clinical algorithms to enable earlier patient identification for enhanced treatment decision-making, risk management and quality improvement.



Join the discussion